Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

Type 1 diabetes in adults: diagnosis and management

NICE guideline
Reference number: NG17
Published: 26 August 2015
Last updated: 17 August 2022

History

Guidance published

Consultation comments and responses (PDF 474 KB)

Published:

29 June 2022
Committee member list (PDF 217 KB)

Published:

29 June 2022
Equality impact assessment 4 - periodontitis (PDF 142 KB)

Published:

29 June 2022

Stakeholder list updated

Stakeholder list (PDF 233 KB)

Published:

28 June 2022

Declaration of interests

Register of interests (PDF 1.24 MB)

Published:

28 June 2022

Draft guidance consultation

Draft guidance consultation
Draft guideline (PDF 211 KB)

Published:

30 March 2022
Evidence review (PDF 2.58 MB)

Published:

30 March 2022
Equality impact assessment 3 (PDF 150 KB)

Published:

30 March 2022
Comments form (MSWord 40 KB)

Published:

30 March 2022

Committee meetings

Committee meeting
Minutes 9 (PDF 184 KB)

Published:

14 April 2021
Minutes 14 (PDF 225 KB)

Published:

07 February 2022
Minutes 15 (PDF 177 KB)

Published:

09 May 2022

Update on 31 March 2022

Surveillance consultation
Surveillance consultation
Consultation questions (PDF 91 KB)

Published:

26 May 2022
Consultation summary of evidence (PDF version) (PDF 607 KB)

Published:

26 May 2022
Surveillance review proposal (online version)
Surveillance review proposal (PDF version) (PDF 147 KB)

Published:

26 May 2022
Stakeholder list updated
Stakeholder list (PDF 50 KB)

Published:

19 May 2022
Guidance published
Consultation comments and responses (PDF 1.61 MB)

Published:

31 March 2022
Committee member list (PDF 201 KB)

Published:

31 March 2022
Equality impact assessment 4 - diagnosis (PDF 108 KB)

Published:

31 March 2022
Equality impact assessment 4 - CGM (PDF 150 KB)

Published:

31 March 2022
Declaration of interests
Register of interests (PDF 1.22 MB)

Published:

30 March 2022
Draft guidance consultation
Draft guidance consultation
Draft guideline (PDF 344 KB)

Published:

24 November 2021
Evidence review - CGM (PDF 3.96 MB)

Published:

24 November 2021
Evidence review - diagnosis (PDF 3.51 MB)

Published:

24 November 2021
Economic report (PDF 882 KB)

Published:

24 November 2021
Equality impact assessment 3 (PDF 149 KB)

Published:

24 November 2021
Comments form (MSWord 41 KB)

Published:

24 November 2021
Scope published
Final scope (PDF 295 KB)

Published:

19 October 2021
Pre-consultation documents released
Economic plan - CGM (PDF 126 KB)

Published:

15 October 2021
Review questions - CGM (PDF 165 KB)

Published:

15 October 2021
Review questions - diagnosis (PDF 146 KB)

Published:

15 October 2021
Search strategies - CGM (PDF 318 KB)

Published:

15 October 2021
Search strategies - diagnosis (PDF 464 KB)

Published:

15 October 2021

Update on 21 July 2021

Guidance published
Committee member list (PDF 192 KB)

Published:

21 July 2021
Guidance consultation comments and response (PDF 1.27 MB)

Published:

21 July 2021
Equality impact assessment 4 (PDF 129 KB)

Published:

21 July 2021
Declaration of interests
Register of interests (PDF 1.16 MB)

Published:

21 July 2021
Stakeholder list updated
Stakeholder list (PDF 271 KB)

Published:

20 July 2021
Equality and health inequalities assessment
Equality impact assessment 3 (PDF 146 KB)

Published:

28 June 2021
Draft guidance consultation
Draft guidance consultation
Evidence review A - Long acting insulins for type 1 diabetes (PDF 10.42 MB)

Published:

21 April 2021
Draft guideline (PDF 699 KB)

Published:

21 April 2021
Economic report (PDF 2.1 MB)

Published:

21 April 2021
Comments form (MSWord 37 KB)

Published:

21 April 2021
Pre-consultation documents released
Review questions (PDF 181 KB)

Published:

31 March 2021
Search strategies (PDF 463 KB)

Published:

31 March 2021
Economic plan (PDF 141 KB)

Published:

31 March 2021
Scope published
Final scope (PDF 295 KB)

Published:

20 July 2020

Original development on 26 August 2015

Stakeholder list updated
Stakeholder list (PDF 150 KB)

Published:

02 July 2019
Surveillance consultation
Surveillance consultation
Comments form (MSWord 29 KB)

Published:

25 April 2019
Surveillance review proposal (PDF 1.28 MB)

Published:

25 April 2019
Equality impact assessment - guideline development
Equality impact assessment - guideline development (PDF 122 KB)

Published:

26 August 2015
Stakeholder comments table
Stakeholder comments table (PDF 2.08 MB)

Published:

26 August 2015
Equality impact assessment
Equality impact assessment (PDF 107 KB)

Published:

22 July 2015
Guideline consultation
Guideline consultation information
Draft NICE guideline (PDF 748 KB)

Published:

10 December 2014
Draft guideline (PDF 10.36 MB)

Published:

10 December 2014
Appendices information
Appendices A - F (PDF 7.95 MB)

Published:

10 December 2014
Appendix G (PDF 8.73 MB)

Published:

10 December 2014
Appendices H - U (PDF 8.45 MB)

Published:

10 December 2014
Health economic plan, review questions and search strategy
Health economic plan, review questions and search strategy
Health economic plan (PDF 22 KB)

Published:

21 October 2014
Review questions (PDF 184 KB)

Published:

21 October 2014
Search strategies (PDF 832 KB)

Published:

21 October 2014
Equality impact assessment form - scoping
Equality impact assessment form - scoping (PDF 151 KB)

Published:

12 April 2013
Guideline development and consultation
Guideline development and consultation
GDG membership list (PDF 11 KB)

Published:

07 November 2012
GDG minutes
GDG 14 minutes (PDF 87 KB)

Published:

28 April 2014
GDG 12-13 minutes (PDF 90 KB)

Published:

28 April 2014
GDG 11 minutes (PDF 129 KB)

Published:

04 February 2014
GDG 9-10 minutes (PDF 89 KB)

Published:

20 December 2013
GDG 8 minutes (PDF 108 KB)

Published:

17 December 2013
GDG 7 minutes (PDF 35 KB)

Published:

17 December 2013
GDG 6 minutes (PDF 96 KB)

Published:

17 December 2013
GDG 5 minutes (PDF 58 KB)

Published:

03 June 2013
Stakeholder list and how to register
List of registered stakeholders (PDF 136 KB)

Published:

24 March 2015
Scoping workshop, consultation and final scope
Scoping workshop, consultation and final scope
Stakeholder comments (PDF 641 KB)

Published:

07 November 2012
Final scope (PDF 89 KB)

Published:

07 November 2012
Scoping workshop notes (PDF 287 KB)

Published:

04 July 2012
Joint diabetes guidelines: draft scopes consultation information
Draft scope (PDF 82 KB)

Published:

04 July 2012
Type 2 diabetes: draft scope (PDF 91 KB)

Published:

04 July 2012
Diabetes in children (update): draft scope (PDF 89 KB)

Published:

04 July 2012
Diabetes in pregnancy (update): draft scope (PDF 101 KB)

Published:

04 July 2012
List of registered stakeholders (PDF 136 KB)

Published:

24 March 2015
Type 2 diabetes information
Diabetes in pregnancy (update): list of registered stakeholders (PDF 101 KB)

Published:

16 January 2015
Diabetes in children and young people: list of registered stakeholders (PDF 129 KB)

Published:

24 March 2015